ClearMask joins Trajectory Next, post-accelerator program for medical technologies
Betamore, Johns Hopkins Technology Ventures and the University of Maryland, Baltimore’s UM Ventures announced the 2018 cohort of Trajectory Next, a post-accelerator program designed to support digital health, bio-health and life sciences ventures.
In addition to ClearMask, the companies selected for the program included: CardioCube, Bayesian Health, Revolve Biotechnologies, Inc., NextStep Robotics Inc., LyfLynks, Inc., B.Well, and Sonavex.
The 12-week program is funded by TEDCO and will offer support, guidance and access to the combined networks of Betamore, JHTV and UM Ventures. Cohort members receive customized services and training around the building of sales channels, facilitating pilot programs, restructuring product management, legal support, user research, market development and recruiting.